Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AEMD Aethlon Medical

Market Closed 12-12 16:00:00 EST

3.40

+0.00

0.00%

盘后3.40

+0.000.00%

18:29 EST

High3.46	Low3.32	Vol28.60K
Open3.40	D1 Closing3.40	Amplitude4.12%
Mkt Cap2.59M	Tradable Cap2.45M	Total Shares761.20K
T/O97.02K	T/O Rate3.97%	Tradable Shares720.00K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AEMD","market":"US","secType":"STK","nameCN":"Aethlon Medical","latestPrice":3.4,"timestamp":1765573200000,"preClose":3.4,"halted":0,"volume":28596,"hourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.4,"latestTime":"18:29 EST","volume":124,"amount":418.11,"timestamp":1765582152953},"delay":0,"floatShares":720000,"shares":761200,"eps":-68.10675,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 EST","open":3.4,"high":3.4562,"low":3.316,"amount":97021.0978776,"amplitude":0.041235,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-68.10675,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.4,"preHourTrading":{"tag":"盘前","latestPrice":3.42,"preClose":3.4,"latestTime":"09:22 EST","volume":38,"amount":130.650802,"timestamp":1765549324734},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.4,"latestTime":"18:29 EST","volume":124,"amount":418.11,"timestamp":1765582152953},"volumeRatio":0.14612714034583635,"impliedVol":3.8125,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/AEMD/wiki","defaultTab":"wiki","newsList":[{"id":"2589381847","title":"BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381847?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:15","pubTimestamp":1764944139,"startTime":"0","endTime":"0","summary":"BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant InducementDec 5 (Reuters) - Aethlon Medical Inc AEMD.O:AETHLON MEDICAL ANNOUNCES PRICING OF A PRIVATE PLACEMENT AND WARRANT I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUA9CKCYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","AEMD","BK4583"],"gpt_icon":0},{"id":"2589681844","title":"Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2589681844","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589681844?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:15","pubTimestamp":1764944100,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Dec. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc.  , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 595,897 shares of common stock , together with warrants to purchase up to an aggregate 1,042,820 shares of common stock, in a private placement priced at-the-market under Nasdaq rules. The combined effective offering price for each share of common stock  and accompanying warrants is $4.03. The warrants will have an exercise price of $4.03 per share, will be exercisable upon shareholder approval, and will expire on the five and one-half year anniversary from such date of shareholder approval.Maxim Group LLC is acting as the sole placement agent in connection with the offering.The offer and sale of the foregoing securities are being made in a private placement under Section 4 of the Secu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4583","BK4568"],"gpt_icon":0},{"id":"2588053472","title":"Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053472","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053472?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:02","pubTimestamp":1764680572,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. has announced the publication of preclinical data demonstrating that the GNA affinity resin in its Hemopurifier device binds to extracellular vesicles  in plasma samples from Long COVID patients and decreases inflammatory microRNAs. The results, published on November 20, 2025, in the pre-print archive bioRxiv, indicate that the Hemopurifier removes both large and small EVs, which are elevated in Long COVID patients compared to recovered controls. Additionally, NanoString analyses identified seven EV-associated microRNAs significantly reduced by treatment with the GNA affinity resin. The company stated that these findings support further investigation of the Hemopurifier in Long COVID. The results from this preclinical study have been submitted for consideration to a peer-reviewed journal and have not yet been presented in a clinical trial context.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT str","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL54kBQw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4568","BK4082","AEMD"],"gpt_icon":0},{"id":"2583188506","title":"Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583188506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583188506?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:56","pubTimestamp":1763124968,"startTime":"0","endTime":"0","summary":"In a report released on November 12, Anthony Vendetti from Maxim Group maintained a Hold rating on Aethlon Medical. The company’s shares closed yes...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-hold-rating-on-aethlon-medical-aemd-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-hold-rating-on-aethlon-medical-aemd-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEMD"],"gpt_icon":0},{"id":"2583583813","title":"Aethlon Medical Reports Q2 Cost Reduction and Ongoing Cancer Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583813","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583813?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:16","pubTimestamp":1762982197,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. reported financial results for its fiscal second quarter ended September 30, 2025. The company announced a 48% reduction in operating expenses, reflecting ongoing cost management efforts. As of September 30, 2025, Aethlon held a cash balance of approximately $5.8 million. The company confirmed it has resolved Nasdaq compliance matters and remains listed on the Capital Market. Operationally, recruitment is underway for Cohort 2 of the Australian oncology trial under an amended protocol. Aethlon also continues its collaboration with UCSF on Long COVID research, with a manuscript in preparation for a peer-reviewed journal. Additionally, the company initiated evaluation of its Hemopurifier device compatibility with a simplified blood treatment system.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLbhZgRc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4568","BK4583"],"gpt_icon":0},{"id":"2583838235","title":"Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583838235","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583838235?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:16","pubTimestamp":1762982176,"startTime":"0","endTime":"0","summary":"Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(3.74) per share which missed the analyst consensus estimate of $(3.66) by 2.1 percent. This is a 133.75 percent decrease over losses of $(1.60) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48819392/aethlon-medical-q2-eps-3-74-misses-3-66-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2583887285","title":"Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583887285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583887285?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:15","pubTimestamp":1762982101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA9G4VDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEMD","BK4583","BK4082","BK4568"],"gpt_icon":0},{"id":"2583589299","title":"Aethlon Medical Inc - Qtrly Loss per Share $3.74","url":"https://stock-news.laohu8.com/highlight/detail?id=2583589299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583589299?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:15","pubTimestamp":1762982101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA9G4VDP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","AEMD","BK4583"],"gpt_icon":0},{"id":"2582327400","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582327400?lang=en_us&edition=fundamental","pubTime":"2025-11-12 19:00","pubTimestamp":1762945200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CI&T Inc. Class A                               3Q       .10        AMC. ·Digi Intl Inc.                                  4Q       .51    4:00 PM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO","CRMT","ANNX","ALC","CURI","IBTA","RSKD","PYPD","ARDT","LUNG","AFYA","AMAT","AFCG","CRMD","ABOS","CLBT","BLDP","AUTL","ALMS","AVBP","GUTS","CABA","ALH","CELC","ARCO","ARX","BABA","CAAP","CINT","ACXP","AYTU","BEEM","ABEO","IMRX","AKRO","MGX","ABSI","ATAT","ATXS","AEMD","CSCO","CCAP","AEBI","TWFG","ASND","ALUR","CPRT","CREX","AIRG"],"gpt_icon":1},{"id":"2581306038","title":"Aethlon Medical Inc  expected to post a loss of $3.66 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581306038","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581306038?lang=en_us&edition=fundamental","pubTime":"2025-11-08 08:15","pubTimestamp":1762560907,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc  expected to post a loss of $3.66 a share - Earnings Preview Aethlon Medical Inc AEMD.OQ AEMD.O is expected to  show no change in quarterly revenue when it reports  results on Nove","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nL8N3WK00D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4568","AEMD","BK4082"],"gpt_icon":0},{"id":"2581588821","title":"Aethlon Medical Inc. to Report Fiscal Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581588821","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581588821?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:01","pubTimestamp":1762520516,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via PR Newswire  on November 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL7TsfT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AEMD","BK4568","BK4583"],"gpt_icon":0},{"id":"2581926440","title":"Aethlon Medical Regains Nasdaq Compliance After Stock Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2581926440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581926440?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:48","pubTimestamp":1762440510,"startTime":"0","endTime":"0","summary":"Aethlon Medical ( ($AEMD) ) has issued an announcement. On November 5, 2025, Aethlon Medical, Inc. announced it had regained compliance with the Na...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-regains-nasdaq-compliance-after-stock-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-regains-nasdaq-compliance-after-stock-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","BK4082","TSYW.SI","NVIW.SI","QID","TQQQ","PSQ","USAW.SI","BK4568","NQmain","SQQQ","QLD","USJW.SI","AEMD",".IXIC","BK4583"],"gpt_icon":0},{"id":"2581916450","title":"Aethlon Medical Inc - Regains Compliance With Nasdaq Minimum Bid Price - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581916450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581916450?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:19","pubTimestamp":1762438793,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI17R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4583","BK4568","AEMD"],"gpt_icon":0},{"id":"2577142493","title":"Aethlon Medical Faces Nasdaq Non-Compliance Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2577142493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577142493?lang=en_us&edition=fundamental","pubTime":"2025-10-23 04:57","pubTimestamp":1761166633,"startTime":"0","endTime":"0","summary":"Aethlon Medical ( ($AEMD) ) has provided an update. On October 16, 2025, Aethlon Medical received a notification from Nasdaq regarding non-complian...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-faces-nasdaq-non-compliance-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-faces-nasdaq-non-compliance-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","QLD","QID","USJW.SI","BK4583","BK4568","NQmain","PSQ","TSYW.SI","NVIW.SI","USAW.SI","MNQmain","SQQQ","AEMD",".IXIC","TQQQ"],"gpt_icon":0},{"id":"2577316059","title":"Aethlon Medical Faces Nasdaq Delisting After Failing Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2577316059","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577316059?lang=en_us&edition=fundamental","pubTime":"2025-10-23 04:18","pubTimestamp":1761164303,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. has announced that it received a notice from the Nasdaq Stock Market stating the company is not in compliance with the minimum bid price requirement, as its common stock closed below $1.00 per share for 30 consecutive business days. To address this, Aethlon has implemented a 1-for-10 reverse stock split, effective October 16, 2025, with trading under the new structure beginning October 20, 2025. The company has requested a hearing before the Nasdaq Hearings Panel, which will temporarily prevent any immediate suspension or delisting actions, and its shares will continue to trade under the symbol \"AEMD\" while it seeks to regain compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL4t04jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4583","BK4568","AEMD"],"gpt_icon":0},{"id":"2576982520","title":"Aethlon Medical trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2576982520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576982520?lang=en_us&edition=fundamental","pubTime":"2025-10-18 07:50","pubTimestamp":1760745014,"startTime":"0","endTime":"0","summary":"19:50 EDT Aethlon Medical (AEMD) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4568","AEMD","BK4583"],"gpt_icon":0},{"id":"2575741423","title":"Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575741423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575741423?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:17","pubTimestamp":1760620624,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nFWN3VX2MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","AEMD","BK4583"],"gpt_icon":0},{"id":"2575413741","title":"Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575413741","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575413741?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:16","pubTimestamp":1760620569,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. has announced a 1-for-10 reverse stock split of its common shares, effective October 16, 2025. The company's stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market starting October 20, 2025, under the existing symbol \"AEMD.\" The CUSIP number for the common stock will change to 00808Y604.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL21LqMj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","AEMD","BK4583"],"gpt_icon":0},{"id":"2573995701","title":"BRIEF-Aethlon Medical's Hemopurifier® Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2573995701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573995701?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:35","pubTimestamp":1759840552,"startTime":"0","endTime":"0","summary":"BRIEF-Aethlon Medical's Hemopurifier Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical TrialOct 7 (Reuters) - Aethlon Medical Inc AEM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUA83TDKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4583","BK4568","AEMD"],"gpt_icon":0},{"id":"2573270952","title":"Aethlon Medical Announces Promising Early Data from Australian Clinical Trial of Hemopurifier® in Cancer Patients Resistant to Anti-PD-1 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2573270952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573270952?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:02","pubTimestamp":1759838577,"startTime":"0","endTime":"0","summary":"Aethlon Medical Announces Promising Early Data from Australian Clinical Trial of Hemopurifier in Cancer Patients Resistant to Anti-PD-1 Therapy. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via PR Newswire  on October 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL3JR0jb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4568","AEMD","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aethlonmedical.com","stockEarnings":[{"period":"1week","weight":-0.0811},{"period":"1month","weight":-0.1905},{"period":"3month","weight":-0.5603},{"period":"6month","weight":-0.8068},{"period":"1year","weight":-0.8838},{"period":"ytd","weight":-0.9506}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.405859},{"month":2,"riseRate":0.1,"avgChangeRate":-0.160963},{"month":3,"riseRate":0.2,"avgChangeRate":-0.122222},{"month":4,"riseRate":0.2,"avgChangeRate":-0.105016},{"month":5,"riseRate":0.3,"avgChangeRate":-0.125643},{"month":6,"riseRate":0.8,"avgChangeRate":0.195518},{"month":7,"riseRate":0.2,"avgChangeRate":-0.085564},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.064693},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.084082},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.111246},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.001468},{"month":12,"riseRate":0.454545,"avgChangeRate":0.030193}],"exchange":"NASDAQ","name":"Aethlon Medical","nameEN":"Aethlon Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aethlon Medical,AEMD,Aethlon Medical股票,Aethlon Medical股票老虎,Aethlon Medical股票老虎国际,Aethlon Medical行情,Aethlon Medical股票行情,Aethlon Medical股价,Aethlon Medical股市,Aethlon Medical股票价格,Aethlon Medical股票交易,Aethlon Medical股票购买,Aethlon Medical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction